NeoMed Management: Funding, Team & Investors | Startup Intros

Loading organizations...

NeoMed Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 21, 2024	Endosense	$29.4M Other Equity	3i, NeoMed Management	—
Feb 1, 2021	Oxular	$37.0M Series B	Forbion	V-Bio Ventures
Feb 5, 2020	JenaValve Technology	$50.0M Other Equity	Andrew Hack	Andera Partners, Gimv, Legend Capital, RMM, Valiance, VI Partners
Apr 1, 2017	Arsanis	$46.0M Series D	Bill & Melinda Gates Foundation	Flagship Ventures, NanoDimension, OrbiMed, Polaris Partners, Timothy A. Springer, Alexandria Venture Investments, Anna Maria and Stephen Kellen Foundation, EMBL Ventures, Google Ventures, Polaris Partners, SV Health Investors
Jul 19, 2016	Oxular	$20.3M Series A	—	Hovione Scientia, Imperial Innovations, Christina Takke
Mar 9, 2016	4Tech	$29.0M Series B	RMM, Jan Pensaert	—
Dec 21, 2015	Axonics Modulation Technologies	$38.5M Series B	—	Shahzad Malik, Cormorant Asset Management, Darren Cai, Erik Amble, Barry Keenan
Aug 1, 2015	Avitide	$8.0M Series C	—	Borealis Ventures, Flagship Ventures, InterWest, OrbiMed, Polaris Partners, SV Health Investors, Vivo Capital, Wildcat Ventures, N5 Capital, Claudio Nessi, Terrance McGuire, SV Health Investors
Jan 7, 2015	Genkyotex	$19.7M Series D	BioMedPartners, Claudio Nessi, VI Partners	Eclosion, Vesalius Biocapital
Apr 1, 2014	JenaValve Technology	$10.0M Series C	—	Atlas Venture, Craft Ventures, Felicis Ventures, Kapor Capital, Lowercarbon Capital, Redpoint Ventures, SV Angel, Eric Hahn, Tim Ferriss, Gimv, Legend Capital, Omega Funds, RMM, Sunstone Capital, Valiance, VI Partners
Mar 25, 2014	Axonics Modulation Technologies	$32.6M Series A	—	Darren Cai, Erik Amble
Sep 1, 2013	Arsanis	$20.0M Series B	Claudio Nessi	Flagship Ventures, NanoDimension, OrbiMed, Polaris Partners, Timothy A. Springer, Polaris Partners, SV Health Investors
Jul 1, 2013	JenaValve Technology	$63.0M Series C	—	Andera Partners, Atlas Venture, Craft Ventures, Felicis Ventures, INKEF Capital, Kapor Capital, Lowercarbon Capital, Redpoint Ventures, SV Angel, Eric Hahn, Tim Ferriss, Patrick Van Beneden, Xiangyu Ouyang, Omega Funds, Sunstone Capital, VI Partners
Jun 7, 2013	Diagnoplex	$1.4M Other Equity	Debiopharm Diagnostics	Initiative Capital Romandie
Oct 4, 2011	Creabilis	$19.9M Series B	Abbott Biotech Ventures	Sofinnova Partners
Aug 1, 2011	Vessix Vascular	$23.0M Series B	—	Andera Partners, Christopher Weil & Company, DiNovA Capital, Fjord Invest, Vince Burgess
Jan 18, 2011	Diagnoplex	$10.4M Series A Extension	Debiopharm	Initiative Capital Romandie, Novartis
Oct 20, 2010	Vessix Vascular	$4.7M Other Equity	NeoMed Management	Olav Bergheim, Christopher Weil & Company
Mar 31, 2010	JenaValve Technology	$25.7M Series B	Gimv	Atlas Venture, Sunstone Capital, VI Partners